About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Saccadometry in Primary Headache Syndromes | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNCT01395264

Saccadometry in Primary Headache Syndromes

Migraine is one of the commonest neurological disorders, affecting up to 12% of the general population, but remains relatively under-diagnosed and under-treated. Migraine has a wide socioeconomic impa...

Lead sponsor: Tim Young•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Tim Young

As above

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Male or female and aged between 18 and 60 years in good general health apart from suffering from headaches (test group).
•2. Migraine and cluster headache will be diagnosed according to ICHD-II diagnostic criteria (6).
•3. Migraineurs must suffer at least two migraine attacks per year and no more than 5 attacks per month.
•\-

Exclusion Criteria

•1. Any other neurological disorder such as stroke, multiple sclerosis, epilepsy, concussion within the past year, psychiatric disorders, visual disorders.
•2. Use of migraine prophylactic medication in the last month or acute migraine therapy in the 3 days prior to testing.
•3. Patients on any medication to treat depression in their case
•4. Headache during testing or within 3 days before and after testing.
•\-

Related studies

Chiropractic Care for Episodic Migraine

NCT06229834 · Episodic Migraine

Cardiopulmonary Responses to 6-Minute Stepper Test in Bronchiectasis Versus Healthy Controls

NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched

RECRUITINGPhase 3

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

NCT07388498 · Uncontrolled Gout

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

BE WELL With Migraine: Brain Education and WELLness With Migraine

NCT05987592 · Migraine

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 31, 2017Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment42

Start dateAug 2011

Last updatedOct 31, 2017

Condition

Migraine Cluster Headache Control Menstrual Migraine

Locations shown

Neurology Department, Whittington Hospital

London

The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, and The John Radcliffe hospital, Oxford, The Whittington Hospital N19 5NF London

London

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 31, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions